Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |